SCPX Scorpius Holdings Inc.

Price (delayed)

$0.157

Market cap

$4.09M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2

Enterprise value

$15.03M

heat biologics is a clinical-stage company focused on developing its proprietary impact™ (immune pan-antigen cytotoxic therapy), a fully allogeneic (“off-the-shelf”) cell-based immunotherapy for use in the treatment of a wide ...

Highlights
The revenue has soared by 138% YoY and by 43% from the previous quarter
SCPX's gross profit is down by 31% YoY but it is up by 23% QoQ
The quick ratio has plunged by 94% YoY and by 77% from the previous quarter
The gross margin has plunged by 71% YoY and by 14% from the previous quarter

Key stats

What are the main financial stats of SCPX
Market
Shares outstanding
26.08M
Market cap
$4.09M
Enterprise value
$15.03M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.11
Price to sales (P/S)
1.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.75
Earnings
Revenue
$2.23M
EBIT
-$55.6M
EBITDA
-$48.05M
Free cash flow
-$40.39M
Per share
EPS
-$2
Free cash flow per share
-$1.55
Book value per share
$1.39
Revenue per share
$0.09
TBVPS
$2.68
Balance sheet
Total assets
$69.92M
Total liabilities
$36.47M
Debt
$13.25M
Equity
$36.29M
Working capital
-$307,684
Liquidity
Debt to equity
0.37
Current ratio
0.99
Quick ratio
0.28
Net debt/EBITDA
-0.23
Margins
EBITDA margin
-2,157.8%
Gross margin
29.1%
Net margin
-2,333.5%
Operating margin
-2,421.2%
Efficiency
Return on assets
-60.1%
Return on equity
-94.1%
Return on invested capital
-82.3%
Return on capital employed
-122.4%
Return on sales
-2,497.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SCPX stock price

How has the Scorpius Holdings stock price performed over time
Intraday
-1.88%
1 week
-1.75%
1 month
-1.26%
1 year
-79.61%
YTD
-64.34%
QTD
-3.09%

Financial performance

How have Scorpius Holdings's revenue and profit performed over time
Revenue
$2.23M
Gross profit
$648,032
Operating income
-$53.91M
Net income
-$51.96M
Gross margin
29.1%
Net margin
-2,333.5%
The revenue has soared by 138% YoY and by 43% from the previous quarter
The gross margin has plunged by 71% YoY and by 14% from the previous quarter
The company's operating margin rose by 49% YoY and by 33% QoQ
The net margin is up by 48% year-on-year and by 30% since the previous quarter

Growth

What is Scorpius Holdings's growth rate over time

Valuation

What is Scorpius Holdings stock price valuation
P/E
N/A
P/B
0.11
P/S
1.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.75
The EPS has contracted by 21% YoY
The P/B is 88% below the 5-year quarterly average of 0.9 and 63% below the last 4 quarters average of 0.3
Scorpius Holdings's equity has shrunk by 57% YoY and by 26% QoQ
The revenue has soared by 138% YoY and by 43% from the previous quarter
SCPX's price to sales (P/S) is 94% less than its 5-year quarterly average of 30.2 and 83% less than its last 4 quarters average of 11.1

Efficiency

How efficient is Scorpius Holdings business performance
The company's return on equity has shrunk by 125% YoY and by 22% QoQ
The ROA has plunged by 75% YoY and by 14% from the previous quarter
SCPX's return on invested capital has dropped by 73% year-on-year and by 12% since the previous quarter
The ROS has grown by 48% YoY and by 30% from the previous quarter

Dividends

What is SCPX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SCPX.

Financial health

How did Scorpius Holdings financials performed over time
Scorpius Holdings's total assets is 92% more than its total liabilities
The quick ratio has plunged by 94% YoY and by 77% from the previous quarter
The current ratio has dropped by 78% year-on-year and by 34% since the previous quarter
The debt is 63% smaller than the equity
The debt to equity has surged by 61% since the previous quarter
Scorpius Holdings's equity has shrunk by 57% YoY and by 26% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.